Where are we heading with noninvasive clinical vascular physiology? Why and how should we assess endothelial function?

PubWeight™: 0.77‹?›

🔗 View Article (PMC 3157674)

Published in Cardiol Res Pract on August 16, 2011

Authors

Elizabeth A Ellins1, Julian P J Halcox

Author Affiliations

1: Wales Heart Research Institute, Cardiff University, Heath Park, Cardiff CF14 4XN, UK.

Articles cited by this

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (1980) 40.02

Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol (2002) 16.25

Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A (1987) 14.22

Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet (1992) 11.50

Point: Flow-mediated dilation does reflect nitric oxide-mediated endothelial function. J Appl Physiol (1985) (2005) 9.97

Prognostic value of coronary vascular endothelial dysfunction. Circulation (2002) 7.68

Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med (1986) 6.05

Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation (2007) 5.87

Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol (1995) 5.26

Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation (2009) 5.26

Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation (2008) 4.69

Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol (2004) 4.62

Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation (1995) 4.59

Local shear stress and brachial artery flow-mediated dilation: the Framingham Heart Study. Hypertension (2004) 4.56

Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation (1993) 4.53

Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite. Hypertension (2008) 3.99

Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol (1994) 3.71

The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med (1995) 3.60

Effects of diet and exercise on obesity-related vascular dysfunction in children. Circulation (2004) 3.44

Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation (1996) 3.28

Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. Eur Heart J (2010) 3.22

Role of nitric oxide in the regulation of digital pulse volume amplitude in humans. J Appl Physiol (1985) (2006) 3.07

Interrelations between brachial endothelial function and carotid intima-media thickness in young adults: the cardiovascular risk in young Finns study. Circulation (2004) 2.72

Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol (1996) 2.64

Peak vs. total reactive hyperemia: which determines the magnitude of flow-mediated dilation? J Appl Physiol (1985) (2006) 2.62

Statins enhance postischemic hyperemia in the skin circulation of hypercholesterolemic patients: a monitoring test of endothelial dysfunction for clinical practice? J Am Coll Cardiol (2003) 2.59

Methodological approaches to optimize reproducibility and power in clinical studies of flow-mediated dilation. J Am Coll Cardiol (2008) 2.58

Cohort profile: the cardiovascular risk in Young Finns Study. Int J Epidemiol (2008) 2.51

Ultrasound assessment of flow-mediated dilation. Hypertension (2010) 2.48

Mental stress induces transient endothelial dysfunction in humans. Circulation (2000) 2.37

Endothelial function predicts progression of carotid intima-media thickness. Circulation (2009) 2.30

Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation (2000) 2.27

Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation (2000) 2.18

Brachial artery flow-mediated dilation and asymmetrical dimethylarginine in the cardiovascular risk in young Finns study. Circulation (2007) 2.15

Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens (2005) 2.12

Heterogenous nature of flow-mediated dilatation in human conduit arteries in vivo: relevance to endothelial dysfunction in hypercholesterolemia. Circ Res (2001) 2.02

Endothelial dysfunction in childhood infection. Circulation (2005) 1.97

Methodological issues in the assessment of skin microvascular endothelial function in humans. Trends Pharmacol Sci (2006) 1.95

Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study) J Am Coll Cardiol (2000) 1.91

Counterpoint: Flow-mediated dilation does not reflect nitric oxide-mediated endothelial function. J Appl Physiol (1985) (2005) 1.90

Brachial artery vasodilator function and systemic inflammation in the Framingham Offspring Study. Circulation (2004) 1.84

The association between endothelial dysfunction and cardiovascular outcomes in a population-based multi-ethnic cohort. Atherosclerosis (2006) 1.83

Mechanisms of acetylcholine-mediated vasodilatation in young and aged human skin. J Physiol (2005) 1.83

Remote ischemic preconditioning provides early and late protection against endothelial ischemia-reperfusion injury in humans: role of the autonomic nervous system. J Am Coll Cardiol (2005) 1.79

Flow-mediated dilatation following wrist and upper arm occlusion in humans: the contribution of nitric oxide. Clin Sci (Lond) (2001) 1.76

Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level. J Clin Invest (1994) 1.72

Photoplethysmographic assessment of pulse wave reflection: blunted response to endothelium-dependent beta2-adrenergic vasodilation in type II diabetes mellitus. J Am Coll Cardiol (1999) 1.72

Periodontal disease is associated with brachial artery endothelial dysfunction and systemic inflammation. Arterioscler Thromb Vasc Biol (2003) 1.69

Exercise training enhances endothelial function in young men. J Am Coll Cardiol (1999) 1.65

Flow-mediated changes in pulse wave velocity: a new clinical measure of endothelial function. Eur Heart J (2005) 1.64

ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT. Cardiovasc Res (2006) 1.58

What is the most appropriate methodology for detection of conduit artery endothelial dysfunction? Arterioscler Thromb Vasc Biol (2007) 1.56

Ischemic preconditioning prevents endothelial injury and systemic neutrophil activation during ischemia-reperfusion in humans in vivo. Circulation (2001) 1.49

Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia. J Am Coll Cardiol (2000) 1.42

Pulse-wave analysis: clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol (2002) 1.40

Endothelial function in resistance and conduit arteries and 5-year risk of cardiovascular disease. Circulation (2011) 1.40

Assessment of atherosclerosis: the role of flow-mediated dilatation. Eur Heart J (2010) 1.32

Non-invasive assessment of endothelial function: which technique? J Am Coll Cardiol (2006) 1.26

Exercise training in patients with advanced chronic heart failure (NYHA IIIb) promotes restoration of peripheral vasomotor function, induction of endogenous regeneration, and improvement of left ventricular function. Circ Heart Fail (2010) 1.22

Flow-mediated dilation in human brachial artery after different circulatory occlusion conditions. Am J Physiol Heart Circ Physiol (2003) 1.18

Elevated blood pressure in adolescent boys predicts endothelial dysfunction: the cardiovascular risk in young Finns study. Hypertension (2006) 1.17

Cross-sectional evaluation of brachial artery flow-mediated vasodilation and C-reactive protein in healthy individuals. Eur Heart J (2004) 1.13

Effects of antihypertensive drugs on endothelial dysfunction: clinical implications. Drugs (2002) 1.11

Nitric oxide is not obligatory for radial artery flow-mediated dilation following release of 5 or 10 min distal occlusion. Am J Physiol Heart Circ Physiol (2009) 1.07

Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD: clinical evidence for 'pleiotropic' functions of statin therapy. Eur Heart J (2006) 1.07

Prevention of inflammation-induced endothelial dysfunction: a novel vasculo-protective action of aspirin. Circulation (2002) 1.06

Assessment of endothelial function using peripheral waveform analysis: a clinical application. J Am Coll Cardiol (2002) 1.06

Effect of calcium antagonist or beta blockade treatment on nitric oxide-dependent vasodilation and oxidative stress in essential hypertensive patients. J Hypertens (2001) 1.06

Determinants of vascular phenotype in a large childhood population: the Avon Longitudinal Study of Parents and Children (ALSPAC). Eur Heart J (2010) 0.99

Nitric oxide activity in the atherosclerotic human coronary circulation. J Am Coll Cardiol (1997) 0.94

Flow-mediated dilation in patients with coronary artery disease is enhanced by high dose atorvastatin compared to combined low dose atorvastatin and ezetimibe: results of the CEZAR study. Atherosclerosis (2008) 0.94

A single loading dose of clopidogrel causes dose-dependent improvement of endothelial dysfunction in patients with stable coronary artery disease: results of a double-blind, randomized study. Atherosclerosis (2007) 0.93

Variability of peripheral arterial tonometry in the measurement of endothelial function in healthy men. Clin Cardiol (2009) 0.92

Rationale and design of dal-VESSEL: a study to assess the safety and efficacy of dalcetrapib on endothelial function using brachial artery flow-mediated vasodilatation. Curr Med Res Opin (2010) 0.90

The role of flow-mediated dilatation in the evaluation and development of antiatherosclerotic drugs. Curr Opin Lipidol (2009) 0.85

Effect of reactive hyperemia on carotid-radial pulse wave velocity in hypertensive participants and direct comparison with flow-mediated dilation: a pilot study. Angiology (2009) 0.85

Ranolazine improves endothelial function in patients with stable coronary artery disease. Coron Artery Dis (2009) 0.81

Levels of asymmetrical dimethylarginine are predictive of brachial artery flow-mediated dilation 6 years later. The Cardiovascular Risk in Young Finns Study. Atherosclerosis (2010) 0.81

Effects of cilazapril on vascular structure and function in essential hypertension. Hypertension (1996) 0.78

The fate of endothelial function testing: rationale and design of the Firefighters And Their Endothelium (FATE) study. Can J Cardiol (2003) 0.78

Articles by these authors

Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med (2003) 13.84

Predisposition to atherosclerosis by infections: role of endothelial dysfunction. Circulation (2002) 3.09

Survey of physicians' practices in the control of cardiovascular risk factors: the EURIKA study. Eur J Prev Cardiol (2011) 1.25

Vasculopathy in Turner syndrome: arterial dilatation and intimal thickening without endothelial dysfunction. J Clin Endocrinol Metab (2005) 1.12

Does high C-reactive protein concentration increase atherosclerosis? The Whitehall II Study. PLoS One (2008) 1.09

A dose-response study of hormone replacement in young hypogonadal women: effects on intima media thickness and metabolism. Clin Endocrinol (Oxf) (2007) 0.90

Circulating human heat shock protein 60 in the blood of healthy teenagers: a novel determinant of endothelial dysfunction and early vascular injury? Arterioscler Thromb Vasc Biol (2005) 0.87

Childhood origins of arterial disease. Curr Opin Pediatr (2007) 0.83

Vascular impact of progenitor cell mobilisation for cardiac repair post-myocardial infarction. Heart (2009) 0.78

Higher systolic blood pressure with normal vascular function measurements in preterm-born children. Acta Paediatr (2014) 0.78

Dilatation in the femoral vascular bed does not cause retrograde relaxation of the iliac artery in the anaesthetized pig. Acta Physiol (Oxf) (2008) 0.75

The arterial pulse: vascular biology, vascular function testing, and therapies. Cardiol Res Pract (2011) 0.75

Stem cells as future therapy in cardiology. Hosp Med (2005) 0.75